Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan versus ramipril in elderly patients with mild to moderate hypertension
2004-002077-23Phase 3Completed
- Sponsor
- Menarini Group
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olmesartan and ramipril in essential hypertension (2 arms), sponsored by Menarini Group. Started Mar 2005; status: completed.
02
Drugs
olmesartanramipril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2004-002077-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002077-23.